| |
Dr. Foght has over 40 years experience in the healthcare and life
sciences industries. He was co-founder Dupont Pharmaceuticals and
the Founder and President of Vector Securities, a premier investment
banking firm specializing in early-stage biotechnology ventures.
He holds many advisory positions. He is currently Chairman of the
Board of Directors of IllinoisVENTURES LLC, an organization that
commercializes University of Illinois technologies, and on the investment
committee of the Vector Later-Stage Equity Funds and Board of Director
Illinois Emerging Technology Fund.
John is the CEO of PharmaIN Corp, his bio
can be found on the management page.
Elijah is the President and Founder of PharmaIN Corp, his bio
can be found on the management page.
Dr. Salans is an internationally recognized expert in the fields
of diabetes mellitus, obesity, and endocrinology. He has broad and
extensive experience in biomedical research, clinical medicine,
and administration in the pharmaceutical industry, academia, and
in government. Dr. Salans received his M.D. from the University
of Illinois College of Medicine, followed by internship and residency
in internal medicine at Stanford University Medical Center and The
Rockefeller University. Previously he has served as VP, Scientific
and Academic Affairs and Deputy President for the Sandoz Research
Institute, and held top level clinical positions at the NIH. Currently
he is Clinical Professor and member of the Clinical Staff at Mt.
Sinai, Adjunct Professor of Medicine, Columbia University Medical
Center, and serves on the board of Forest Laboratories, Inc.
|
|
